Filing Details
- Accession Number:
- 0001209191-20-013286
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-26 21:17:26
- Reporting Period:
- 2020-02-24
- Accepted Time:
- 2020-02-26 21:17:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651311 | Merus N.v. | MRUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1790357 | Mark Throsby | C/O Merus N.v. Yalelaan 62 Utrecht P7 3584 CM | Evp & Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2020-02-24 | 87,621 | $0.00 | 100,903 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2020-02-24 | 57,088 | $17.74 | 43,815 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Share Option (right to buy) | Disposition | 2020-02-24 | 3,333 | $0.00 | 3,333 | $0.00 |
| Common Shares | Share Option (right to buy) | Disposition | 2020-02-24 | 5,000 | $0.00 | 5,000 | $0.00 |
| Common Shares | Share Option (right to buy) | Disposition | 2020-02-24 | 31,472 | $0.00 | 31,472 | $0.00 |
| Common Shares | Share Option (right to buy) | Disposition | 2020-02-24 | 47,816 | $0.00 | 47,816 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-09-04 | No | 4 | M | Direct | |
| 0 | 2022-06-17 | No | 4 | M | Direct | |
| 0 | 2023-03-16 | No | 4 | M | Direct | |
| 1,017 | 2023-10-30 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- Exercise prices are denominated in Euros and ranged from 1.93 to 7.20, with a weighted average of 4.81.
- Amount represents the weighted average price of shares sold, which ranged from $17.07 to $18.56. Details of individual transactions are available upon request.
- Exercise price is denominated in Euros at 1.93.
- These options are fully vested.
- Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on September 4, 2012.
- Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on June 17, 2014.
- Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on March 16, 2015.
- Exercise price is denominated in Euros at 7.20.
- Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on October 30, 2015.
Billionaire Hedge Funds
